Ledger.Open graph →
SEC Form D · filed July 1, 2020

Amylyx Pharmaceuticals, Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

John C. Ball · Rye, NYExec · DirectorAnthony M. Scaramucci · New York, NYDirectorJoshua Cohen · Cambridge, MAExec · DirectorWalter Gilbert · Cambridge, MADirectorIsaac Cheng · Cambridge, MADirectorBethany A. Uhlein · Rye, NYDirectorBrett S. Messing · New York, NYDirectorApurva Mehta · FORT WORTH, TXDirectorFelix Von Coerper · Cambridge, MADirectorJustin Klee · Cambridge, MAExec · DirectorBruce N. Alpert · Rye, NYExec · DirectorRobert C. Kolodny · Rye, NYDirectorRobert N. Crimmins · Seattle, WAExec · DirectorStephen Chubb · Cambridge, MADirectorAnthonie C. Van Ekris · Rye, NYDirectorStephen Chubb · Cambridge, MADirectorGeorge Milne · Cambridge, MADirectorKuni C. Nakamura · Rye, NYDirectorRex Antinozzi · Traverse City, MIDirectorEric M. Siegal · CHICAGO, ILExecBenjamin Siegel · NEW YORK, NYExec · DirectorPatrick O'Connor · FORT WORTH, TXDirectorDaniel M. Rosenbloom · CHICAGO, ILExecPeter B. Finn · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗